Portrait der Gilead Sciences Aktie
Das Unternehmen Gilead Sciences aus USA ist in den Bereichen Chemie & Pharma, Biotechnologie & Pharmazeutika, Biotechnologie, Pharma tätig.
Gilead Sciences ist in mehr als 83 ETFs enthalten und somit ein eher allgemein bekannter Wert. Der Spitzenreiter iShares Nasdaq US Biotechnology UCITS ETF gewichtet Gilead Sciences mit 7,06% im ETF.
Es ist auch möglich über Anleihen zu investieren. Hier findest du alle Gilead Sciences Anleihen auf einen Blick.
Entdecke die 6 ETFs in denen Gilead Sciences am höchsten gewichtet ist Insgesamt in 83 ETFs enthalten
Dir gefallen die Informationen zu Gilead Sciences?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Zu Trade Republic
Dir gefallen die Informationen zu Gilead Sciences?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Zur Comdirect
Dir gefallen die Informationen zu Gilead Sciences?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Zur ING Diba
Dir gefallen die Informationen zu Gilead Sciences?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Zu BUX Zero
325 News & Informationen zur Gilead Sciences Aktie
Global Pharma and Biotech Clinical Stage Partnering Terms and Agreements Report/Directory 2021: Deal Trends, Players and Financials
/PRNewswire/ — The
GALAPAGOS : ANNOUNCES POSITIVE CHMP OPINION FOR JYSELECA® (FILGOTINIB) FOR THE TREATMENT OF ADULTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS (Form 6-K)
GALAPAGOS ANNOUNCES POSITIVE CHMP OPINION FOR JYSELECA® FOR THE TREATMENT OF ADULTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS
Mechelen, Belgium; 17 September… | September 20, 2021
Aadi Bioscience Appoints Brendan Delaney as Chief Operating Officer
LOS ANGELES, Sept. 20, 2021 (GLOBE NEWSWIRE) — Aadi Bioscience, Inc. (“Aadi”) (Nasdaq: AADI), a clinical-stage biopharmaceutical company focusing on…
Can Covid’s ‘hidden heroes’ save all?
Antivirals, monoclonal antibodies and viral-killing pills are under development, but making them accessible will be a challenge
Barron's Latest Picks And Pans: Apple, Bitcoin, a Goldman Sachs ETF, Nike And More – Bitcoin – United States Dollar ($BTC)
This weekend's Barron's cover story examines the t…
Global Immunology Partnering Deals Report/Directory 2021: Trends, Players and Financials 2014-2021
/PRNewswire/ — Gain comprehensive access to over 850 immunology deal records from this report “Global Immunology Partnering 2014-2021: Deal Trends, Players…
Global Gynecology Partnering Deals Report/Directory 2021: Trends, Players and Financials 2014-2021
/PRNewswire/ — Gain comprehensive access to over 400 gynecology deal records from this report “Global Gynecology Partnering 2010-2021: Deal Trends, Players…
Gritstone Announces Private Placement Financing of $55.0 Million
EMERYVILLE, Calif., Sept. 16, 2021 (GLOBE NEWSWIRE) — Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company developing next…
Global Genetic Disorders Partnering Deals Report/Directory 2021: Trends, Players And Financials 2014-2021
DUBLIN, Sept. 16, 2021 /PRNewswire/ — Gain comprehensive access to over 590 genetic disorders deal records from this report “Global Genetic Disorders
Tech Moves: Bioengineer joins AI2 incubator; Icosavax adds execs, expands board; and more
— The Allen Institute for AI (AI2) added bioengineer Jenny Cronin as an associate working with entrepreneurs in AI2's startup incubator.
Gilead Sciences Might Return To The Glory Days Of Past (NASDAQ:GILD)
Gilead Sciences has a single-digit P/E ratio based on market capitalization that'll enable the company to continue generating strong FCF.
Gilead Sciences, Inc.'s (GILD) CEO Dan O'Day Presents at Morgan Stanley 19th Annual Global Healthcare Conference (Transcript)
Gilead Sciences, Inc. (NASDAQ:GILD) Morgan Stanley 19th Annual Global Healthcare Conference September 15, 2021 12:30 p.m.
Gilead Sciences, Inc. (GILD) CEO Dan O'Day Presents at Morgan Stanley 19th Annual Global Healthcare Conference (Transcript)
Gilead Sciences, Inc. (NASDAQ:GILD) Morgan Stanley 19th Annual Global Healthcare Conference September 15, 2021 12:30 p.m.
Antibody Drug Conjugate Market, 2028
DUBLIN, Sept. 15, 2021 /PRNewswire/ — The
Enterin Announces Appointment of Dr. Roger Mills to Its Board of Directors
PHILADELPHIA, Sept. 13, 2021 (GLOBE NEWSWIRE) — Enterin, Inc., a privately held, Philadelphia-based, clinical-stage biopharmaceutical company pioneering…
American Funds Insurance Series Buys The Home Depot Inc, Danaher Corp, Nestle SA, Sells ASML Holding NV, Tokio Marine Holdings Inc, Koninklijke Philips NV
GuruFocus Article or News written by insider and the topic is about:
Zoom Video Communications : How Gilead Sciences and Logitech Reimagined Their Telephony Strategy with Zoom Phone
Customer Stories, Phone System
How Gilead Sciences and Logitech Reimagined Their Telephony Strategy with Zoom Phone
Graeme Geddes
… | September 9, 2021
Gritstone Announces Presentations At Two Investor Conferences In September
EMERYVILLE, Calif., Sept. 07, 2021 (GLOBE NEWSWIRE) — Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next generation
HOOKIPA Pharma to Participate in Upcoming Investor Conferences in September
NEW YORK and VIENNA, Austria, Sept. 07, 2021 — HOOKIPA Pharma Inc. , a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform, today announced… | September 7, 2021
ImmunityBio : Builds Commercial Team with the Appointment of Seasoned Marketing and Reimbursement Executives
Biopharma leaders bring proven market development talents in urology and oncology to bolster company’s commercialization plan and long-term growth plans
Helen Luu, former CEO of Cell BT, is… | September 7, 2021
ImmunityBio Builds Commercial Team With The Appointment Of Seasoned Marketing And Reimbursement Executives
ImmunityBio, Inc. IBRX, a clinical-stage immunotherapy company, today announced two key executive appointments that bring industry-leading market growth and
Cyclodextrin Market size would exceed USD 390 million valuation by 2027, Says to Global Market Insights Inc.
The growth of the cyclodextrin market is driven by burgeoning demand for remdesivir injections due to COVID-19, expanding cosmetics & personal care…
Nancy Pelosi's husband up $700K on CrowdStrike stock purchase
House Speaker Nancy Pelosi’s husband, Paul Pelosi, has made over $700,000 of unrealized gains in CrowdStrike stock.
VectivBio Announces Results Of Extraordinary General Meeting
BASEL, Switzerland, Sept. 03, 2021 (GLOBE NEWSWIRE) — VectivBio Holding AG (“VectivBio”) (Nasdaq: VECT), a clinical-stage biopharmaceutical company pioneering
Gilead Sciences (GILD) Outpaces Stock Market Gains: What You Should Know
Gilead Sciences (GILD) closed the most recent trading day at $72.34, moving +0.65% from the previous trading session.
Gilead Sciences (GILD) Outpaces Stock Market Gains: What You Should Know
Gilead Sciences (GILD) closed the most recent trading day at $72.34, moving +0.65% from the previous trading session.
Gilead Sciences (GILD) Outpaces Stock Market Gains: What You Should Know
Gilead Sciences (GILD) closed the most recent trading day at $72.34, moving +0.65% from the previous trading session.
Gilead Sciences (GILD) Outpaces Stock Market Gains: What You Should Know
Gilead Sciences (GILD) closed the most recent trading day at $72.34, moving +0.65% from the previous trading session.
Gilead Sciences (GILD) Outpaces Stock Market Gains: What You Should Know
Gilead Sciences (GILD) closed the most recent trading day at $72.34, moving +0.65% from the previous trading session.
Gilead Sciences (GILD) Outpaces Stock Market Gains: What You Should Know
Gilead Sciences (GILD) closed the most recent trading day at $72.34, moving +0.65% from the previous trading session.
Ex-Dividenden-Tage September 2021 – Jung in Rente
Ein passives Einkommen aus Dividenden ebnet mir den Weg zur Frührente. Einmal im Monat berichte ich hier über anstehende Ex-Dividenden-Tage.
Apple Ranked Among September’s Top Buys As Investors Dive Into Fall
Q.ai runs daily factor models to get the most up-to-date reading on stocks and ETFs. This month, our deep-learning algorithms have identified Apple among others.
First Patient Gets Dose in Pfizer's Oral COVID-19 Drug Trial
Global Lipid Contract Manufacturing Market Report 2021-2030 With Focus On The Capabilities Of Contract Service Providers Engaged In This Domain
DUBLIN, Sept. 1, 2021 /PRNewswire/ — The “Lipid Contract Manufacturing Market by Type of Lipid , Triglycerides, Sphingolipids, Neutral Lipids, Others),
Pfizer, Merck launch new trials of oral COVID-19 drugs
Pfizer Inc and Merck & Co Inc announced on Wednesday new trials of their experimental oral antiviral drugs for COVID-19 as the race to develop an…
Setting The Bar High For Generic Medicines
As the pandemic upended the healthcare supply chain over the past year, one company in Bangladesh did not only strive to ensure the continued distribution of medicines across the country, but also introduced its own antidote against Covid-19.
9 top Bay Area biotechs that VCs say are poised to take off in the next year
Venture capitalists said nine Bay Area startups are poised to take off in the next year. Shutterstock Insider asked top venture capitalists to…
Pfizer starts dosing patients in oral Covid drug trial
Pfizer's mid-to-late-stage trial in 1,140 participants would study the therapy, PF-07321332, in combination with a low dose of ritonavir, which has been used with other antivirals too
Pfizer starts dosing patients in oral COVID-19 drug trial By Reuters
Pfizer starts dosing patients in oral COVID-19 drug trial
Pfizer starts dosing patients in oral COVID-19 drug trial
Pfizer Inc said on Wednesday it had started dosing in a mid-to-late-stage trial of its oral antiviral therapy for COVID-19 in non-hospitalized, symptomatic…